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ABSTRACT
Diabetic nephropathy (DN) is one of complications in diabetic patients manifested by 
microalbuminuria with minimal level of 30 mg/24 hour which is measured at least 2 times 
in the period of  3 to 6 months. Microalbuminuria can be measured either albumin excretion 
rate (AER) or albumin creatinine ratio (ACR). Measurement of ACR is an alternative 
parameter recommended by WHO in 2011 to diagnose diabetic nephropathy since it is 
more convenient, fast and not requires special preparation. The purpose of this study 
was to investigate accuracy of ACR to diagnose DN in type 2 diabetes mellitus (T2DM) 
patients.This was a diagnostic test study involving 80 T2DM patients. In this study ACR 
value equal or more than 30 mg/g was independently and blindly compared with AER as 
the gold standard. The data were analyzed using 2x2 tables in order to calculate sensitivity, 
specificity, positive predictive value (PPV), and negative predictive value (NPV). Other 
data were analyzed using statistic descriptive. Eighty T2DM patients consisting of 38 
males and 42 females participated in this study. They had suffered from T2DM on average 
9.5 years, and the average of ACR value was 55.5 mg/g. Total result of true positive and 
true negative was 77. Three result were false negative but none of false positive result. 
The ACR value equal or more than 30 mg/g had sensitivity, specificity, PPV, and NPV of 
95.9%, 100%, 100%, and 66.7% respectively. In conclusion, the ACR value equal or more 
than 30 mg/g derived from morning urine sample can be used to  diagnose DN in T2DM 
patients.
ABSTRAK
Nefropati diabetik (ND) merupakan salah satu komplikasi pada pasien diabetes yang 
dimanifestasikan sebagai mikroalbuminuria dengan nilai minimal 30 mg/24 jam yang 
diukur setidaknya 2 kali dalam selang waktu 3 sampai 6 bulan. Mikroalbuminuria dapat 
diukur dengan laju eksresi albumin (albumin excretion rate/AER) atau rasio albumin 
terhadap kreatinin (albumin creatinine ratio/ACR). Pengukuran ACR merupakan parameter 
alternatif yang direkomendasikan Organisasi Kesehatan Dunia pada tahun 2011 untuk 
mendiagnosis ND karena lebih nyaman, cepat dan tidak memerlukan persiapan khusus. 
Penelitian ini bertujuan untuk menentukan ketepatan ACR dalam mendiagnosis nefropati 
diabetik pada pasien diabetes mellitus tipe 2 (DMT2). Dalam penelitian ini nilai ACR sama 
atau lebih dari 30 mg/g dibandingkan dengan baku emas AER secara bebas dan tersamar. 
Data dianalisis menggunakan tabel 2 X 2 untuk menetapkan sensitivitas, spesifisitas, nilai 
ramal positif, dan nilai ramal negatif. Data lain dianalisis menggunakan statistik deskriptif. 
Sebanyak 80 pasien DMT2 yang terdiri dari 38 laki-laki dan 42 perempuan terlibat dalam 
penelitian ini. Mereka rata-rata menderita penyakit ini 9,5 tahun dengan rerata nilai ACR 
55,5 mg/g. Total hasil positif benar dan negatif benar sebanyak 77. Tiga hasil menunjukkan 
negatif palsu dan tidak ditemukan hasil positif palsu. Nilai ACR sama atau lebih dari 30 
mg/g memiliki sensitivitas, specifisitas, nilai ramal positif, dan nilai ramal negatif secara 
berurutan sebesar 95,9%, 100%, 100%, and 66,7%. Hal ini dapat disimpulkan bahwa nilai 
ACR sama atau lebih dari 30 mg/g yang diperoleh dari sampel urin pagi dapat digunakan 
untuk mendiagnosis ND pada pasien DMT2. 
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INTRODUCTION
Diabetic nephropathy (DN) is the 
most frequent single cause of end-stage 
renal disease (ESRD) in many countries. 
Hyperfiltration and microalbuminuria 
characterize the clinical stages of DN. 
Increased levels of albumin in the urine have 
been clearly established as an important 
determinant for renal complication of 
diabetes. Screening for increased albumin 
excretion has therefore been advocated to 
identify individual at risk for renal disease 
progression in a timely manner. However, 
there is still continuing uncertainty as to how 
urine should be collected and which urinary 
proteins should be specifically measured for 
prediction of renal events.1
Albumine creatinine ratio (ACR) has 
been proposed as both a screening and 
diagnostic test for kidney disease. Screening 
for microalbuminuria is essential as it 
allows interventions aimed at preventing 
diabetic nephropathy and part of the 
everyday treatment of diabetic patient for 
detecting kidney disease progression and 
also evaluation of treatment effect, therefore 
samples providing immediate and reliable 
results are highly desirable. Numerous recent 
studies have been shown that early morning 
urinary ACR for screening purpose is also a 
predictor of overt DN and is useful to identify 
patient at risk as it is less influenced by the 
factors such as hydration status, physical 
activity and concentration bias.2
Type 2 diabetes mellitus (T2DM) 
typically asymptomatic in the early stages 
of development and is generally identified 
only after 4 to 7 years after onset of the 
disease.3 Diabetes mellitus is often not 
diagnosed until complications appear, and 
approximately 30% of patients with diabetes 
may be left undiagnosed. Microvascular and 
macrovascular complications sometimes 
already developed, even in pre-diabetic 
stage. As many as 25% of people with a new 
diagnosis of diabetes already have diabetic 
retinopathy (DR) or microalbuminuria.4
It is estimated that one-third of patients 
with type 1 diabetes mellitus (T1DM) and 
one-sixth of patients with T2DM will develop 
DN. When DN has developed, the interval to 
ESRD varies from the first 4 years to more 
than 10 years. Based on more recent studies, 
it was similar between T1DM and T2DM. In 
present study using T2DM patients because 
its prevalence  in Dr. Sardjito General 
Hospital was higher than that T1DM.5
Microalbuminuria is a laboratory 
parameter that can be used as predictors for 
the development of nephropathy in diabetic 
patients. However, it has an ostacle since it 
requires a 24-hour urine sample which causes 
a lot of discomfort for patient. Fortunely, 
nowadays it has been developed other tool 
to measure microalbuminuria by measuring 
either albumin excretion rate (AER), or 
ACR.2 The lack of information regarding 
the use of ACR in the determination of 
microalbuminuria has an impact on delay 
in diagnosis of DN. Therefore, efforts have 
been done in order to avoid the development 
of terminal renal failure that require 
multidisciplinary management in addition to 
its poor prognosis and cost.1
Currently, the data regarding ACR 
especially its sensitivity and specificity are 
still not sufficient, thus its implementation 
is still limited. In Indonesian population, 
especially in the Yogyakarta Special Region, 
ACR test for the diagnosis of DN in T2DM 
population is rarely used. Therefore, this 
study tried to measure the sensitivity and 
specificity of ACR with a cutoff value of 30 
mg/g compared with AER value using 24-
hour urine sample for diagnosis of DN.
MATERIALS AND METHODS
Reagents and subjects
Sample used in this study were 24-
hour urine, urine at random, EDTA blood 
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sample as well as blood serum. In addition, 
reagensia kit to measure albumin, creatinine, 
HbA1c, blood glucose were also needed. This 
was a diagnostic test study where the ACR 
was independenly and blindly compared 
with the AER involving 80 T2DM patients 
with suspected DN who visited in Internal 
Medicine Outpatient Clinic of Dr. Sardjito 
General Hospital and agreed to undergo 
ACR and AER tests throughout 2015. The 
inclusion criteria were diabetic patients (a 
minimum of 4 years) with suspected DN 
and give written informed consent. Those 
patients who suffered from either urinary 
tract infections, or congestive heart failure, 
or liver dysfunction, or pregnancy, or 
incomplete or missing medical record data 
were excluded from this study. Protocol of 
this study has been approved by the Medical 
and Health Research Ethics Committee, 
Faculty of Medicine, Public Health and 
Nursing, Universitas Gadjah Mada, 
Yogyakarta.
Protocol of the study
Subjects had their urine albumin and 
urine creatinine levels measured using 
morning urine sample. The ACR values 
were calculated manually, dividing urinary 
albumin by urine creatinine levels. Gold 
standard in this study was AER that measured 
from urine albumin level with 24-hour 
urine. Standard microalbuminuria criteria 
used in this study were in accordance with 
2002 NKF/KDOQ recommendation, ACR 
between 30-300 mg/g, while AER 30-300 
mg/24 hour.6
Eligible subjects filled out a 
questionnaire for baseline characteristics 
data such as age, sex, education, occupation, 
history of hypertension, history of heart 
disease, duration of diabetes and blood 
pressure (BP). Physical examination was 
conducted which also include weight, height, 
BP measurements.
Laboratory tests were carried out for 2 
day. In day I, samples were taken for fasting 
blood glucose, 2 hour post prandial blood 
glucose, HbA1c, and spot urine. Fasting 
blood glucose  tests, 2 hour post prandial 
blood glucose and HbA1c were measured 
from 2 mL of venous blood sample and 
the tests were condected in the same day 
of sampling. Subjects on the day I was 
also asked to collect 5 mL urine sample for 
urine albumin and creatinine measurements. 
Urine samples were then transferred into 
Eppendorf tubes using a standardized 
micropipette, then labeled and kept at -20°C, 
pooled them up to sufficient number of 
samples were acomplished. Subjects were 
also given written and oral instruction for 
24-hour urine collection (when collection 
began, first urination was discarded then 
second and subsequent urination collected 
for 24 hour) into a 2.500 mL threaded cap 
bottle urine container.
On day 2, 24-hour urine samples were 
collected. The collected 24-hour urine 
samples were homogenized by flipping 
the bottles as much as 5 times, after which 
the urine volume was recorded. Most 
homogeneous urine samples were transferred 
into eppendorf  tubes using a standardized 
micropipette, then labeled and stored at 
-20°C, pooled until urine albumin tests 
performed after certain number of samples 
were collected. 
Fasting and 2 hour post prandial blood 
glucose level were measured according to 
hexokinase method using COBASS 6000 
ANALYZER. The assay is based upon the 
reduction of NAD+ through a coupled reaction 
with glucose-6-phosphate dehydrogenase 
and is determined spectrophotometrically 
by measuring the increase in absorbance 
at 340 nm. Hemoglobin A1c (HbA1c) 
was measured with ion-exchange High-
performance liquid chromatography (HPLC) 
method using Biorad D-10 ANALYZER. 
The ion-exchange high-performance liquid 
chromatography (HPLC) is based on 
chromatographic separation of HbA1c on a 
cation exchange cartridge in human whole 
blood. Urinary albumin was measured 
using a immunoturbidimetric method. The 
principle of immunoturbidimetric assay 
is albumin in the urine reacts with specific 
antibodies, then added polyethylene glycol 
will precipitate immune complexes that 
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would cause turbidity. Turbidity is measured 
by photometric and its value is proportional 
to the levels of albumin in the urine. 
Urinary creatinine was measured using Jaffe 
method using COBASS 6000 ANALYZER. 
The principle Jaffe method is in alkaline 
atmosphere with picric acid will form 
compounds saffron. This color change will 
be measured by using a photometer.6
Albumin excretion rate was urinary 
albumin excretion within 24 hours. It was 
measured using immunoturbidimetric 
method using COBASS 6000 ANALYZER. 
Albumin excretion rate is the gold standard 
to assess microalbuminuria. In current study, 
DN is defined by AER value of ≥30 mg/24 
hour. The ACR was calculated manually 
by dividing the urinary albumin by urinary 
creatinine values, and the results were 
expressed in mg/g. In the current study, DN 
is defined by ACR value of ≥30 mg/g.2 To 
assess reliability, before running any tests, 
analytic tests were first completed using 
calibration test, accuracy test and precision 
test.6
Data analysis
Data characteristics was presented 
descriptively in mean and standard deviation 
(SD) if data had normal distribution or in 
median and minimum-maximum values if 
did not have normal distribution. Normality 
for continuous data was tested using 
Kolmogorov-Smirnov test. Categorical 
data were presented in proportion. To test 
differences in mean age, fasting and 2 hour 
post prandial blood glucose, independent 
t-test was used when data were normally 
distributed and Mann-Whitney test when data 
were not normally distributed. Meanwhile, 
to investigate differences in proportion, 
Chi-Square test was used. Results were 
considered significant if p values less than 
0.05 with 95% confidence intervals. 
Diagnostics performance were analyzed 
by 2 X 2 table and result was presented in 
sensitivity (Sn), specificity (Sp), accuracy, 
positive predictive value (PPV), negative 
predictive value (NPV), likelihood ratio 
(LR) for test  positive and negative results.  
RESULTS 
Characteristics of subjects
A total of 110 subjects were given a 
questionnaire, unfortunately 16 subjects 
did not return their questionnaires, thefore 
they were considered resigned from study. 
From the remained subjects (94 subjects), 
nine subjects did not collect 24-hour urine 
sample, five subjects without data of volume 
of 24-hour urine sample so that they were 
excluded from the study. Finally, 80 subjects 
were included in analysis. Total subject 
of the study were 80 subject consisted of 
females 42 (52.5%) and males 38 (47.5%). 
Based on age, 40 subjects were more than 
60 years (50%) and 40 subjects were less 
than 60 years (50%). The characteristics of 
subjects are presented in TABLE 1.
 
TABLE 1. Characteristics of subjects
Characteristics n %
Gender
•	 Male 38 47.5
•	 Female 42 52.5
Age
•	 ≤ 60 years 40 50.0
•	 > 60 years 40 50.0
Education
•	 Elementary School 8 10.0
•	 Junior High School 5 6.3
•	 Senior High School 37 46.3
•	 Higher education 30 37.5
Occupation
•	 Household 20 25.0
•	 Professional 2 2.5
•	 Government employ-
ees 6 7.5
•	 Private 2 2.5
•	 Entrepreneur 6 7.5
•	 Other 44 55.0
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TABLE 2. Characteristics of subject between ND and Non ND groups
Characteristics ND (n=74) Non ND (n=6) p
BMI (mean±SD kg/m2) 24.86 ± 3.37 25.24 ± 2.81 0.790
Hipertension [n (%)]
•	 Yes 42 (56.8) 3 (50.0) 1,000
•	 No 32 (43.2) 3 (50.0)
Heart disease  [n (%)]
•	 Yes 23 (31.1) 3 (50.0) 0.384
•	 No 51 (68.9) 3 (50.0)
Dyslipidemia [n (%)]
•	 Yes 47 (63.5) 5 (83.3) 0.659
•	 No 27 (36.5) 1 (16.7)
Stroke [n (%)]
•	 Yes 7 (9.5) 2 (33.3) 0.133
•	 No` 67 (90.5) 4 (66.7)
Duration of DM (mean±SD year) 10.12 ± 7.21 9.33 ± 9.05 0.728
BP (mean ± SD mmHg)
•	 Sistolic 129.84±16.17 125.00±10.49 0.521
•	 Diastolic 79.39±9.43 80.00±5.48 0.854
Fasting glucose (mean±SD mg/dL) 160.38 ± 68.61 139.83 ± 17.95 0.826
2 h PP glucose (mean±SD mg/dL) 227.05 ± 91.58 195.17 ± 52.09 0.517
Creatinine serum (mean±SD mg/dL) 1.10 ± 0.23 0.87± 0.15 0.630
HbA1c (mean±SD %) 7.97 ± 2.21 7.67 ± 0.68 0.891
Note: BMI (body mass index); BP (blood pressure); 2 h pp (2 hours post prandial)
FIGURE 1. Scatter plot of AER value based on duration of DM
Total subject of the study were 80 subject 
consisted 74 subject with DN and 6 subject 
non DN. No significantly different in body 
mass index (BMI), history of hypertension, 
heart disease, dyslipidemia, stroke, duration 
of DM, fasting and 2 hour post prandial lood 
glucose level, and HbA1C  level between 
subjects with DN and non DN was observed 
(TABLE 2).
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ACR diagnostic performance
The ACR diagnostic performance was 
tested using 2x2 table with AER as the gold 
standard for DN. It was found that both true 
positive and true negative rate totally 77. It 
was also found 3 false negative result but 
none of result was false positive (TABLE 
3). In present study, there were 3 subjects of 
It was found that AER values tend to be 
higher in patients with longer duration of 
DM. Patients with longer duration of DM 
normally had higher AER (FIGURE 1).
TABLE 3. Analysis using 2 x 2 table to 
define ACR performance to 
diagnose DN
ND Non ND Total
ACR
•	 ≥ 30 mg/g 71 0 71
•	 < 30 mg/g 3 6 9
Total 74 6 80
TABLE 4. Diagnostic performance of ACR 
to detect DN 
Performance of ACR Value 95% CI
Sensitivity (%) 95.9 88.6 – 99.2
Specificity (%) 100 54 – 100
Accuracy (%) 96.3 92.0 – 100
Positive predictive value (%) 100 100 – 100
Negative predictive value (%) 66.7 35.9 – 97.5
Positive likelihood ratio (LR+) ~ ~
Negative likelihood ratio (LR-) 0.04 0.01 – 0.1
false negative diagnostic test result means 
when viewed from the ACR value, was not 
the subject with DN, but when viewed from 
the AER value included in subject with DN. 
The performance of ACR to diagnose DN 
were as follows sensitivity 95.9%; specificity 
100%; positive predictive value 100%; 
negative predictive value 66.7% (TABLE 4). 
FIGURE 1. Scatter plot of AER value based on duration of DM
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TABLE 5 as well as FIGURE 2 show 
the diagnostic performance of ACR ranging 
from 28 to 32 mg/g with 1 mg/g interval. It 
was shown that ACR value equal or more 
than 30 mg/g has the best performance to 
diagnose DN. 
TABLE 5. Diagnostic performance of ACR at several cutoff values
ACR level (mg/g) Sensitivity (%) 1-Specificity (%)
≥ 32 
97.3 16.7
< 32 
≥ 31 
95.9 0
< 31
≥ 30
95.9 0
< 30
≥ 29
93.2 0
< 29
≥ 28
90.5 0
< 28
FIGURE 2. Receiver operating characteristic curve (ROC) of ACR
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DISCUSSION
The study found higher AER values 
in subjects with longer duration of DM. It 
proved that the disease has a progressive 
characteristic. Generally DN will be 
diagnosed after 4 years duration of DM and 
level of AER might be more than 300 mg/24 
hours. It indicated that kidney function start 
to decline due to lack of blood glucose control 
or the start of chronic hyperglycemia. After 
the tenth year of disease, AER values tend 
to return into the range of 200-300 mg/24 
hours. This is because of management with 
anti-diabetic and anti-hypertensive that have 
also function as renal protector.7,8
The study found at the level equal or 
more than 30 mg/g, ACR has sensitivity and 
specificity 95.9% and 100% respectively. 
In present study obtained high sensitivity 
ACR values. High sensitivity ACR values 
can be used for screening DN especially 
for patients with chronic hyperglycemia. 
Previous studies reported higher specificity 
ACR values can be used for diagnostic 
purposes. Valizadeh et al.9 reported a similar 
study involving 201 T2DM outpatients, 
aged more than 40 years, and use spot urine 
sample.  They use the same cut off value of 
ACR report a different result i.e. sensitivity 
of 100% and specificity of 93.8%. They also 
found that ACR value was correlated with 
AER (r = 0.89; p<0.0001). Another similar 
study conducted by Jafar et al.10 involved 
577 subjects, and used spot urine sample. 
They reported that ACR value with cut off 
value 30 mg/g has sensitivity and specificity 
86% and 90%, respectively. Another study 
conducted by Sampaio et al.11 involved T1 
and T2DM patient with majority female, 
and mean of age was 31 years old. Based 
on cut off value of ACR 27.3 mg/g they 
reported that ACR has sensitivity and 
specificity 100% and 73%, respectively. 
Yamamoto et al.12 conducted a study on 228 
T2DM outpatients with female majority 
with mean of age of 60 years.  Twenty four 
urine samples were tested for albumin, while 
early morning urine samples were tested for 
albumin and creatinine. They found that the 
use of ACR with cutoff value of 28.7 mg/g, 
it has sensitivity and specificity 88% and 
88%, respectively.
Chae et al.13 conducted a study with the 
aim to investigate the correlation between 
ACR and AER. Subjects consisted of 113 
children and adults with T1- and T2DM 
patients, with mean age of 15 years  and 
predominantly male subjects. They found 
that ACR value has a good correlation with 
AER value.
Wu et al.14 conducted a study which 
involved 200 T2DM patients with mean age 
of 40 years to assess the accuracy of ACR 
compared with the gold standard AER. They 
reported that ACR with cut off value of 30 
mg/g has sensitivity and specificity 87% 
and 88% respectively. Both sensitivity and 
specificity reported was lower than that in 
the our study, because the urine sample used 
were not in accordance with NKF/KDOQ 
2002 recommendations. 
Another study was conducted to 
investigate the accuracy of total protein 
creatinine ratio  in urine to diagnosis DN 
among T2DM patients. This ratio was 
independently and blindly compared with 
AER as the reference standard. The result 
showed that this ratio had a sensitivity, 
specificity, PPV, and NPV of 97.4%, 100%, 
100%, and 81.8% respectively.15
CONCLUSION
Albumin creatinine ratio with cutoff 
value of 30 mg/g has sensitivity, specificity, 
PPV, NPV, LR-, and LR+ of 95.9%, 100%, 
100%, 66.7%, 0.04, and infinite respectively 
for the diagnosis of DN. The ACR value of 
30 mg/g with a morning urine sample can be 
used to diagnose DN in T2DM population.
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